The quest for effective and safe weight loss solutions has long been a focus of medical research. In recent years, a novel ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

For people like me, who have struggled for years with accepting our large bodies, the worship of the new GLP-1 weight loss drugs has been disheartening.

Read here for an analysis of LifeVantage's (LFVN) stock surge post GLP-1 trial, cautioning on pricing, retention, and ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

Discover the potential of GLP-1 medications like Ozempic and Mounjaro in treating a wide range of conditions, from diabetes to addiction.

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.